Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thymosin beta-15B is a small, non-enzymatic, actin-binding protein encoded by the TMSB15B gene in humans. It belongs to the beta-thymosin family and plays an essential role in organizing the cytoskeleton by binding and sequestering G-actin monomers, thus inhibiting actin polymerization[1][2][3]. This function is crucial for cell motility, migration, angiogenesis, and wound healing. In the thymus, thymosin beta-15B is secreted by thymic epithelial cells and regulates their spatial development and differentiation, influencing thymocyte maturation and thymic output. While it is functionally identical in protein sequence to Thymosin beta-15A, these two proteins are independently regulated at the gene level[3]. Thymosin beta-15B is associated with the regulation of immune cell development and may play a role in pathological processes, such as tumor metastasis, certain immune disorders, and aging of the immune system, but it is not currently considered a classical drug target or receptor[1][2].
No established mechanisms of drug action targeting Thymosin beta-15B; general actions are via its protein function (actin monomer binding, regulation of actin dynamics)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thymosin beta-15B (TMSB15B).